Novo Nordisk reports cyberattack as UK gives Wegovy pill the nod

Pharmaceutical giant Novo Nordisk says data related to clinical trial participants was stolen as part of a cyberattack. The affected patient data was pseudonymized and not directly linked to names or other direct identifiers, the company said. The maker of the Wegovy weight-loss drug said the affected data types include patient ID, information on trial participation, gender, year of birth, biomarkers, health/immunogenicity data, and lifestyle factors including smoking status, alcohol use, and BM